Search Results - "E Voll"
-
1
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Published in Proceedings of the National Academy of Sciences - PNAS (25-05-2010)“…Systemic lupus erythematosus (SLE) is an autoimmune disease in which patients develop autoantibodies to DNA, histones, and often to neutrophil proteins. These…”
Get full text
Journal Article -
2
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
Published in Annals of the rheumatic diseases (01-07-2015)“…To investigate whether bortezomib, a proteasome inhibitor approved for treatment of multiple myeloma, induces clinically relevant plasma cell (PC) depletion in…”
Get more information
Journal Article -
3
High‐mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus
Published in Journal of internal medicine (01-10-2011)“… Urbonaviciute V, Voll RE (Friedrich‐Alexander University of Erlangen‐Nuremberg, Erlangen; and University Medical Centre Freiburg, Freiburg/Breisgau;…”
Get full text
Journal Article Conference Proceeding -
4
B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients
Published in Arthritis research & therapy (18-05-2017)“…B cell depletion with rituximab (RTX) is approved for treatment of rheumatoid arthritis (RA) and ANCA-associated vasculitides (AAV). Recently, RTX has been…”
Get full text
Journal Article -
5
Increased binding of anti-dsDNA antibodies to short oligonucleotides modified with topoisomerase I reveals a potential new enzyme function independent from DNA relaxation
Published in BMC research notes (28-10-2023)“…Topoisomerase I (topo I) is a highly conserved enzyme which is known to reduce torsional stress at double-stranded (ds) DNA. Torsional stress induced by…”
Get full text
Journal Article -
6
Pathogenesis of autoimmunity in common variable immunodeficiency
Published in Frontiers in immunology (01-01-2012)“…Common variable immunodeficiency (CVID) presents in up to 25% of patients with autoimmune (AI) manifestations. Given the frequency and early onset in some…”
Get full text
Journal Article -
7
Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis
Published in Orphanet journal of rare diseases (13-12-2022)“…Hepatitis E virus (HEV) infection is a frequent cause of acute viral hepatitis. Immunocompromised patients are at increased risk for viral infection and…”
Get full text
Journal Article -
8
Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE
Published in The Journal of experimental medicine (22-12-2008)“…Autoantibodies against double-stranded DNA (dsDNA) and nucleosomes represent a hallmark of systemic lupus erythematosus (SLE). However, the mechanisms involved…”
Get full text
Journal Article -
9
Streptobacillus moniliformis and IgM and IgG Immune Response in Patient with Endocarditis
Published in Emerging infectious diseases (01-03-2024)“…We describe a case of endocarditis caused by Streptobacillus moniliformis bacteria, a known cause of rat-bite fever, in a 32-year-old woman with pet rats in…”
Get full text
Journal Article -
10
Factors masking HMGB1 in human serum and plasma
Published in Journal of leukocyte biology (01-01-2007)“…High mobility group box 1 protein (HMGB1) is a ubiquitously expressed architectural chromosomal protein. Recently, it has become obvious that HMGB1 can also…”
Get full text
Journal Article -
11
Circulating multimeric immune complexes contribute to immunopathology in COVID-19
Published in Nature communications (26-09-2022)“…A dysregulated immune response with high levels of SARS-CoV-2 specific IgG antibodies characterizes patients with severe or critical COVID-19. Although a…”
Get full text
Journal Article -
12
Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
Published in Cells (Basel, Switzerland) (06-07-2020)“…Deregulated NF-k activation is not only involved in cancer but also contributes to the pathogenesis of chronic inflammatory diseases like rheumatoid arthritis…”
Get full text
Journal Article -
13
CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1
Published in Frontiers in immunology (24-05-2021)“…ObjectivesANCA-associated vasculitides (AAV) affect small- and medium-sized blood vessels. In active disease, vessel wall infiltrates are mainly composed of…”
Get full text
Journal Article -
14
Machine learning for precision diagnostics of autoimmunity
Published in Scientific reports (13-11-2024)“…Early and accurate diagnosis is crucial to prevent disease development and define therapeutic strategies. Due to predominantly unspecific symptoms, diagnosis…”
Get full text
Journal Article -
15
Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides
Published in PloS one (21-05-2012)“…To assess the impact of immunosuppressive therapy with cyclophosphamide (CYC) and rituximab (RTX) on serum immunoglobulin (Ig) concentrations and B lymphocyte…”
Get full text
Journal Article -
16
Impact of tofacitinib treatment on human B-cells in vitro and in vivo
Published in Journal of autoimmunity (01-02-2017)“…Abstract B-cells are pivotal to the pathogenesis of rheumatoid arthritis and tofacitinib, a JAK inhibitor, is effective and safe in its treatment. Tofacitinib…”
Get full text
Journal Article -
17
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
Published in Rheumatic & musculoskeletal diseases open (01-01-2021)“…IntroductionWhether patients with inflammatory rheumatic and musculoskeletal diseases (RMD) are at higher risk to develop severe courses of COVID-19 has not…”
Get full text
Journal Article -
18
JAK inhibitors differentially modulate B cell activation, maturation and function: A comparative analysis of five JAK inhibitors in an in-vitro B cell differentiation model and in patients with rheumatoid arthritis
Published in Frontiers in immunology (26-01-2023)“…Janus kinase (JAK) inhibitors have been approved for the treatment of several immune-mediated diseases (IMIDs) including rheumatoid arthritis (RA) and…”
Get full text
Journal Article -
19
Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide
Published in Arthritis research & therapy (02-12-2019)“…Elevated levels of C-reactive protein (CRP) in systemic sclerosis (SSc) have been linked to early inflammatory stages of the disease. This study has been…”
Get full text
Journal Article -
20
Naive- and Memory-like CD21low B Cell Subsets Share Core Phenotypic and Signaling Characteristics in Systemic Autoimmune Disorders
Published in The Journal of immunology (1950) (15-10-2020)“…An expansion of CD21low B cells has been described in a variety of diseases associated with persistent immune stimulation as in chronic infection,…”
Get full text
Journal Article